230 related articles for article (PubMed ID: 24888722)
1. Abnormal cell proliferation in the p75NTR-positive basal cell compartment of the esophageal epithelium during squamous carcinogenesis.
Okumura T; Shimada Y; Sakurai T; Hori R; Nagata T; Sakai Y; Tsukada K
Dis Esophagus; 2015 Oct; 28(7):634-43. PubMed ID: 24888722
[TBL] [Abstract][Full Text] [Related]
2. Expression of p53-related protein p63 in the gastrointestinal tract and in esophageal metaplastic and neoplastic disorders.
Glickman JN; Yang A; Shahsafaei A; McKeon F; Odze RD
Hum Pathol; 2001 Nov; 32(11):1157-65. PubMed ID: 11727253
[TBL] [Abstract][Full Text] [Related]
3. Enhanced cancer stem cell properties of a mitotically quiescent subpopulation of p75NTR-positive cells in esophageal squamous cell carcinoma.
Kojima H; Okumura T; Yamaguchi T; Miwa T; Shimada Y; Nagata T
Int J Oncol; 2017 Jul; 51(1):49-62. PubMed ID: 28534989
[TBL] [Abstract][Full Text] [Related]
4. p75 neurotrophin receptor expression is a characteristic of the mitotically quiescent cancer stem cell population present in esophageal squamous cell carcinoma.
Yamaguchi T; Okumura T; Hirano K; Watanabe T; Nagata T; Shimada Y; Tsukada K
Int J Oncol; 2016 May; 48(5):1943-54. PubMed ID: 26984177
[TBL] [Abstract][Full Text] [Related]
5. Ki-67 and ProExC are useful immunohistochemical markers in esophageal squamous intraepithelial neoplasia.
Wang WC; Wu TT; Chandan VS; Lohse CM; Zhang L
Hum Pathol; 2011 Oct; 42(10):1430-7. PubMed ID: 21420715
[TBL] [Abstract][Full Text] [Related]
6. MN antigen expression in normal, preneoplastic, and neoplastic esophagus: a clinicopathological study of a new cancer-associated biomarker.
Turner JR; Odze RD; Crum CP; Resnick MB
Hum Pathol; 1997 Jun; 28(6):740-4. PubMed ID: 9191010
[TBL] [Abstract][Full Text] [Related]
7. DNA ploidy, P53 expression, and cellular proliferation in normal epithelium and squamous dysplasia of non-cancerous and cancerous human oesophagi.
Itakura Y; Sasano F; Date F; Kato K; Sekine H; Mori S; Nagura H
Anticancer Res; 1996; 16(1):201-8. PubMed ID: 8615609
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical location of the p75 neurotrophin receptor (p75NTR) in oral leukoplakia and oral squamous cell carcinoma.
Kiyosue T; Kawano S; Matsubara R; Goto Y; Hirano M; Jinno T; Toyoshima T; Kitamura R; Oobu K; Nakamura S
Int J Clin Oncol; 2013 Feb; 18(1):154-63. PubMed ID: 22170235
[TBL] [Abstract][Full Text] [Related]
9. Significant association between 53 BP1 expression and grade of intraepithelial neoplasia of esophagus: Alteration during esophageal carcinogenesis.
Ueki N; Akazawa Y; Miura S; Matsuda K; Kurohama H; Imaizumi T; Kondo H; Nakashima M
Pathol Res Pract; 2019 Nov; 215(11):152601. PubMed ID: 31570283
[TBL] [Abstract][Full Text] [Related]
10. The abnormal expression of retinoic acid receptor-beta, p 53 and Ki67 protein in normal, premalignant and malignant esophageal tissues.
Xu M; Jin YL; Fu J; Huang H; Chen SZ; Qu P; Tian HM; Liu ZY; Zhang W
World J Gastroenterol; 2002 Apr; 8(2):200-2. PubMed ID: 11925591
[TBL] [Abstract][Full Text] [Related]
11. γ-Glutamylcyclotransferase as a novel immunohistochemical biomarker for the malignancy of esophageal squamous tumors.
Takemura K; Kawachi H; Eishi Y; Kitagaki K; Negi M; Kobayashi M; Uchida K; Inoue J; Inazawa J; Kawano T; Board PG
Hum Pathol; 2014 Feb; 45(2):331-41. PubMed ID: 24342434
[TBL] [Abstract][Full Text] [Related]
12. Alterations of p53, cyclin D1 and pRB expression in the carcinogenesis of esophageal squamous cell carcinoma.
Kawakubo H; Ozawa S; Ando N; Kitagawa Y; Mukai M; Ueda M; Kitajima M
Oncol Rep; 2005 Dec; 14(6):1453-9. PubMed ID: 16273238
[TBL] [Abstract][Full Text] [Related]
13. Self-renewal and chemotherapy resistance of p75NTR positive cells in esophageal squamous cell carcinomas.
Huang SD; Yuan Y; Liu XH; Gong DJ; Bai CG; Wang F; Luo JH; Xu ZY
BMC Cancer; 2009 Jan; 9():9. PubMed ID: 19134212
[TBL] [Abstract][Full Text] [Related]
14. The low-affinity nerve growth factor receptor p75NTR identifies a transient stem cell-like state in oral squamous cell carcinoma cells.
Osman TA; Parajuli H; Sapkota D; Ahmed IA; Johannessen ACh; Costea DE
J Oral Pathol Med; 2015 Jul; 44(6):410-9. PubMed ID: 25212757
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-203 inhibits the progression of esophageal squamous cell carcinoma with restored epithelial tissue architecture in vivo.
Okumura T; Shimada Y; Moriyama M; Takei Y; Omura T; Sekine S; Nagata T; Shimizu K; Tsukada K
Int J Oncol; 2014 Jun; 44(6):1923-32. PubMed ID: 24692008
[TBL] [Abstract][Full Text] [Related]
16. The role of p63 and deltaNp63 (p40) protein expression and gene amplification in esophageal carcinogenesis.
Geddert H; Kiel S; Heep HJ; Gabbert HE; Sarbia M
Hum Pathol; 2003 Sep; 34(9):850-6. PubMed ID: 14562279
[TBL] [Abstract][Full Text] [Related]
17. Role of p53 gene mutations in human esophageal carcinogenesis: results from immunohistochemical and mutation analyses of carcinomas and nearby non-cancerous lesions.
Shi ST; Yang GY; Wang LD; Xue Z; Feng B; Ding W; Xing EP; Yang CS
Carcinogenesis; 1999 Apr; 20(4):591-7. PubMed ID: 10223186
[TBL] [Abstract][Full Text] [Related]
18. Relationship between proliferative activity of cancer cells and clinicopathological factors in patients with esophageal squamous cell carcinoma.
Huang JX; Yan W; Song ZX; Qian RY; Chen P; Salminen E; Toppari J
World J Gastroenterol; 2005 May; 11(19):2956-9. PubMed ID: 15902736
[TBL] [Abstract][Full Text] [Related]
19. [The expression of p53, p16, cyclin D1 in esophageal squamous cell carcinoma and esophageal dysplasia].
Kim SG; Hong SJ; Kwon KW; Jung SW; Kim WY; Jung IS; Ko BM; Ryu CB; Kim YS; Moon JH; Kim JO; Cho JY; Lee JS; Lee MS; Shim CS; Kim BS
Korean J Gastroenterol; 2006 Oct; 48(4):269-76. PubMed ID: 17060721
[TBL] [Abstract][Full Text] [Related]
20. P53 and Ki-67 overexpression in gastroesophageal reflux disease--Barrett's esophagus and adenocarcinoma sequence.
Binato M; Gurski RR; Fagundes RB; Meurer L; Edelweiss MI
Dis Esophagus; 2009; 22(7):588-95. PubMed ID: 19302208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
